Tight junction proteins, adherens junction proteins, and desmosomes facilitate close intercellular contact among the epithelial cells of the intestinal tract
Patients with IBS symptoms, bloating, food sensitivities, chronic inflammation, or post-antibiotic gut damage are common candidates for peptide therapy gut protocols
While individual results vary, many patients experience lasting benefits, especially with appropriate maintenance protocols
However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007
GLP-1 signalling slows gastric emptying and blunts appetite centrally